Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

European Leukemianet

Clinical trials sponsored by European Leukemianet, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a second stop be successful? nilotinib trial for CML relapse Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Can a second stop be successful? nilotinib trial for CML relapse

Disease control Ongoing

This study looks at whether taking nilotinib for two years can help people with chronic myeloid leukemia (CML) stay in remission after stopping their medication a second or third time. About 75 adults who previously tried and failed to stop treatment will take nilotinib and then …

Phase 2 • Sponsor: European LeukemiaNet • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC